Clinical trials
Active, not recruiting Phase 1 Cholangiocarcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 2 |
| Jonsson Comprehensive Cancer Center | 2 |
| M.D. Anderson Cancer Center | 2 |
| NGM Biopharmaceuticals, Inc | 1 |
| Novartis Pharmaceuticals | 1 |
| Soul Medicine Institute | 1 |
| Tyra Biosciences, Inc | 1 |
| University Hospital, Ghent | 1 |
| University of Southern California | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cholangiocarcinoma | 12 |
| Pancreatic Neoplasms | 5 |
| Carcinoma, Hepatocellular | 4 |
| Colorectal Neoplasms | 4 |
| Breast Neoplasms | 3 |
| Esophageal Neoplasms | 3 |
| Ovarian Neoplasms | 3 |
| Prostatic Neoplasms | 3 |
| Stomach Neoplasms | 3 |
| Thyroid Neoplasms | 3 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.